XTRA:SAP
XTRA:SAPSoftware

How Investors Are Reacting To SAP (XTRA:SAP) Deepening AI Partnerships With Lemongrass and RESAAS

In recent days, Lemongrass and RESAAS each announced new partnerships with SAP under the PartnerEdge program, aiming to embed their AI and real-time data solutions more tightly into SAP’s Business Technology Platform and enterprise analytics stack. These collaborations, together with SAP’s emphasis on an application–data–AI flywheel and employee-led innovation, underline how the company is working to keep its software central to mission-critical workflows as customers modernize in an AI...
XTRA:ACT
XTRA:ACTChemicals

Is AlzChem Group (XTRA:ACT) Quietly Recasting Its Growth Story Around Creatine Nutrition Demand?

In December 2025, AlzChem Group AG approved a roughly €120 million investment program to build a more automated creatine production plant and related infrastructure, with phased commissioning scheduled from the second half of 2027 to capture additional demand in sports, food, and health. The company links this capacity expansion to early triple-digit million euro annual sales potential from its Creapure® and Creavitalis® lines, underscoring how nutrition and wellness trends are reshaping its...
XTRA:DB1
XTRA:DB1Capital Markets

Kraken–360T Integration Could Be A Game Changer For Deutsche Börse (XTRA:DB1)

Earlier this month, Kraken and Deutsche Börse Group announced a partnership to connect traditional financial markets with digital assets across trading, custody, settlement, collateral management, and tokenized products, initially via a direct integration between Kraken and FX venue 360T. The collaboration could position Deutsche Börse as a core infrastructure provider for institutional crypto and tokenized asset access in Europe and the U.S., reinforcing its role in the development of...
XTRA:SHL
XTRA:SHLMedical Equipment

How Investors May Respond To Siemens Healthineers (XTRA:SHL) Licensing ALZpath Assay And Confirming Dividend

Siemens Healthineers AG previously announced an annual dividend of €1.00 per share, payable on February 10, 2026, with an ex-dividend date of February 6, 2026 and a record date of February 9, 2026. ALZpath, Inc. has licensed its proprietary pTau217 antibody to Siemens Healthineers, enabling development of an Alzheimer's diagnostic assay for Atellica systems that could expand the company’s higher-value in vitro testing portfolio. We’ll now examine how adding an ALZpath-powered Alzheimer’s...
XTRA:TUI1
XTRA:TUI1Hospitality

TUI (XTRA:TUI1) Valuation Check After Strong Full-Year Results, Dividend Declaration and Improving Investor Sentiment

TUI (XTRA:TUI1) just wrapped up its fiscal year with higher sales and net income than last year, and paired those results with a fresh annual dividend announcement that underlines management’s confidence. See our latest analysis for TUI. The upbeat full year numbers and fresh dividend seem to have lit a fire under sentiment, with a 30 day share price return of 14.61 percent helping push the stock to 8.878 dollars, even though the five year total shareholder return remains negative. This...
XTRA:TMV
XTRA:TMVSoftware

What TeamViewer (XTRA:TMV)'s New Global Inside Sales Leader Means For Shareholders

TeamViewer recently appointed Finn Faldi as Executive Vice President Global Inside Sales, adding him to the Senior Leadership Team to unify inside sales across the Americas, EMEA and APAC, while President TeamViewer Americas Georg Beyschlag is set to depart after more than seven years in leadership roles. Faldi’s return, following his prior tenure scaling TeamViewer’s Americas operations and later advising the company, underscores management’s focus on sharpening its commercial engine to...
XTRA:A1OS
XTRA:A1OSIT

All for One Group (XTRA:A1OS) Q3 EPS Volatility Tests Bullish Margin Expansion Narrative

All for One Group (XTRA:A1OS) has just posted its FY 2025 Q3 numbers, with revenue at €122.8 million and EPS of €0.14, marking another quarter of modest profitability following last year’s improvement in earnings. The company has seen revenue hover around the €122 million to €134 million range over recent quarters, while EPS has swung from €0.11 in FY 2024 Q3 to €1.33 in FY 2025 Q1 and now €0.14 in Q3. This pattern places greater emphasis on how consistently those profits can translate into...
XTRA:LHA
XTRA:LHAAirlines

Evaluating Lufthansa (XTRA:LHA) After Kepler Cheuvreux’s Buy Upgrade and Turnaround Optimism

Deutsche Lufthansa (XTRA:LHA) jumped after Kepler Cheuvreux raised its rating to Buy, highlighting a turnaround plan that is mostly scheduled for execution next year along with improving conditions in long-haul travel. See our latest analysis for Deutsche Lufthansa. The rating upgrade lands on top of already strong momentum, with a 37.48% year to date share price return and a 33.38% one year total shareholder return suggesting confidence in Lufthansa’s multi year recovery story. If this...
XTRA:MVV1
XTRA:MVV1Integrated Utilities

MVV Energie (XTRA:MVV1) Valuation After Profit Drop, Higher Dividend and Faster Green Investment

MVV Energie (XTRA:MVV1) just reported a 15% drop in annual profit as past windfall gains faded, yet it chose to lift its dividend and step up spending on renewables and green heat. See our latest analysis for MVV Energie. Despite the softer earnings, the share price has been steady, with the latest close at €31.60 and a 3 month share price return of 3.61 percent. A 5 year total shareholder return of 48.88 percent suggests patient investors have still been rewarded as the market gradually...
XTRA:HPHA
XTRA:HPHABiotechs

European Opportunities: 3 Penny Stocks With Market Caps Under €100M

As the European markets navigate mixed performances, with notable fluctuations in major indices like Germany’s DAX and France’s CAC 40, investors continue to assess opportunities amidst economic uncertainties. Penny stocks, though a term from past market eras, still hold potential for those seeking value in smaller or newer companies. These stocks can offer affordability and growth potential when supported by strong financials, making them intriguing options for investors looking beyond...
XTRA:JST
XTRA:JSTMachinery

December 2025 European Stocks That May Be Trading Below Fair Value

As of December 2025, the European stock market has shown mixed performance, with indices like Germany's DAX seeing gains while others such as France's CAC 40 have experienced declines. Amidst potential rate hikes from the European Central Bank and economic resilience in the region, investors are keenly searching for stocks that might be trading below their fair value. Identifying undervalued stocks can offer opportunities for investors to capitalize on discrepancies between a company's market...